Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
New immunization study findings recently were published by researchers at Case Western Reserve University, Department of Neurology
September 10th, 2008
A report, 'Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies,' is newly published data in Journal of Biological Chemistry. "Studies in transgenic mice bearing mutated human Alzheimer disease (AD) genes show that active vaccination with the amyloid beta (Abeta) protein or passive immunization with anti-Abeta antibodies has beneficial effects on the development of disease. Although a trial of Abeta vaccination in humans was halted because of autoimmune meningoencephalitis, favorable effects on Abeta deposition in the brain and on behavior were seen," researchers in the United States report. "Conflicting results have...
Source: Vaccine Weekly (2008-09-10)
|
